Perigon Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.77M | Buy |
|
|||||
|
2025
Q2 | $3M | Sell |
|
|||||
|
2025
Q1 | $4.53M | Sell |
|
|||||
|
2024
Q4 | $4.97M | Sell |
|
|||||
|
2024
Q3 | $9M | Buy |
|
|||||
|
2024
Q2 | $8.74M | Buy |
|
|||||
|
2024
Q1 | $7.78M | Buy |
|
|||||
|
2023
Q4 | $5.37M | Buy |
|
|||||
|
2023
Q3 | $4.9M | Buy |
|
|||||
|
2023
Q2 | $3.87M | Buy |
|
|||||
|
2023
Q1 | $4.17M | Buy |
|
|||||
|
2022
Q4 | $3.49M | Buy |
|
|||||
|
2022
Q3 | $3.06M | Buy |
|
|||||
|
2022
Q2 | $1.92M | Buy |
|
|||||
|
2022
Q1 | $2.16M | Sell |
|
|||||
|
2021
Q4 | $2.22M | Buy |
|
|||||
|
2021
Q3 | $2.12M | Buy |
|
|||||
|
2021
Q2 | $1.94M | Buy |
|
|||||
|
2021
Q1 | $1.64M | Buy |
|
|||||
|
2020
Q4 | $644K | Sell |
|
|||||
|
2020
Q3 | $795K | Buy |
|
|||||
|
2020
Q2 | $833K | Sell |
|
|||||
|
2020
Q1 | $685K | Buy |
|
|||||
|
2019
Q4 | $281K | Sell |
|
|||||
|
2019
Q3 | $230K | Hold |
|
|||||
|
2019
Q2 | $237K | Buy |
|
|||||
|
2019
Q1 | $247K | Buy |
|
|||||
|
2018
Q4 | $276K | Sell |
|
|||||
|
2018
Q3 | $288K | Sell |
|
|||||
|
2018
Q2 | $300K | Buy |
|
|||||
|
2018
Q1 | $21K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $207K | Sell |
|
|||||
|
2017
Q2 | $694K | Buy |
|
|||||
|
2017
Q1 | $527K | Buy |
|
|||||
|
2016
Q4 | $488K | Buy |
|
|||||
|
2016
Q3 | $419K | Sell |
|
|||||
|
2016
Q2 | $368K | Buy |
|